Aspirin and risk for gastric cancer: a population-based case-control study in Sweden
about
sameAs
Chronic immune activation and inflammation as the cause of malignancyEffects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysisMolecular alterations in gastric cancer with special reference to the early-onset subtypeRole of Helicobacter pylori in gastric cancer: UpdatesCOX-2 Inhibitors and Gastric CancerCyclooxygenase-2 and gastric carcinogenesisLow-dose aspirin affects the clinicopathological features of gastric cancerNature meets nurture: molecular genetics of gastric cancer.Early-onset gastric cancer: Learning lessons from the youngNSAIDs, Mitochondria and Calcium Signaling: Special Focus on Aspirin/SalicylatesEpidemiology of gastric cancer.At the bedside: Helicobacter pylori, dysregulated host responses, DNA damage, and gastric cancer.Helicobacter pylori and gastric cancer: factors that modulate disease risk.Frequency-risk and duration-risk relationships between aspirin use and gastric cancer: a systematic review and meta-analysisEarly neoplastic progression is complement independent.Association between COX-2 polymorphisms and non-small cell lung cancer susceptibility.Antibiotic treatment and risk of gastric cancer.Chemoprevention of gastric cancer: role of COX-2 inhibitors and other agents.The Effects of Anti-inflammatory Drug Treatment in Gastric Cancer Prevention: an Update of a Meta-analysis.Nonsteroidal anti-inflammatory drug use reduces risk of adenocarcinomas of the esophagus and esophagogastric junction in a pooled analysis.Non-steroidal anti-inflammatory drugs in prevention of gastric cancer.Long-Term Low-Dose Aspirin Use Reduces Gastric Cancer Incidence: A Nationwide Cohort StudyLong-term risk of gastrointestinal cancers in persons with gastric or duodenal ulcers.Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysis.Nonsteroidal antiinflammatory drugs and risk of gastric adenocarcinoma: the multiethnic cohort studyUrinary prostaglandin E2 metabolite and gastric cancer risk in the Shanghai women's health study.Inflammation, tumor necrosis factor and Wnt promotion in gastric cancer development.Cyclooxygenase-2 and gastric cancer.15-hydroxyprostaglandin dehydrogenase is downregulated and exhibits tumor suppressor activity in gastric cancer.A Prospective Study of Urinary Prostaglandin E2 Metabolite, Helicobacter pylori Antibodies, and Gastric Cancer Risk.Activation of peroxisome proliferator-activated receptor gamma suppresses nuclear factor kappa B-mediated apoptosis induced by Helicobacter pylori in gastric epithelial cells.Aspirin and non-steroidal anti-inflammatory drugs use reduce gastric cancer risk: A dose-response meta-analysis.Mechanism and clinical significance of cyclooxygenase-2 expression in gastric cancer.Different cell kinetic changes in rat stomach cancer after treatment with celecoxib or indomethacin: implications on chemopreventionCarpe low-dose aspirin: the new anti-cancer face of an old anti-platelet drug.Late administration of a specific COX-2 inhibitor does not treat and/or prevent progression of gastric tumors in rats submitted to duodenogastric reflux procedure.Statistical model of the interactions between Helicobacter pylori infection and gastric cancer development.Risk of gastric cancer development after eradication of Helicobacter pylori.Associations between aspirin use and the risk of cancers: a meta-analysis of observational studies.The Value of Helicobacter Eradication in Long-term Aspirin Users.
P2860
Q24648532-428AC0C5-805A-4D71-BF2E-6DD683FFE0E9Q24796323-B392AA9D-81EC-4AB6-B087-D876B0CCC619Q26764919-B117E3FE-6528-4887-9E91-CE2B30393C8DQ26766696-31D77109-DBC9-4172-820B-4D5592F5E09AQ27692701-8AF69989-ECFA-4E22-95BB-80859D305D5BQ28184447-E25D1F53-8495-450E-8E29-BF921419A0D0Q28195916-B48612E6-9839-47EE-AA7D-615FB2FAC279Q33347546-B362287C-97D1-4160-99C9-164E4F524718Q33350295-8F40F06D-C853-4E28-A07F-98CD2B337FD8Q33664334-F37964A5-749D-420B-BB7F-EF2021C5C0D4Q33788193-881EA7E5-F011-4BC4-9700-3634EBB26916Q33911623-5844EFF1-99F8-4BF1-AF4C-386623ACFC55Q34189885-ACD6648F-7B98-4B86-9B88-92AD66EC95C3Q34923812-6A551595-4289-4222-A1DF-FB733E304AB8Q34928831-6E1A8D40-6827-4447-B902-C6A35CDABA64Q35632350-BE966FF8-B762-4BFA-95FF-65A18198C799Q35760519-CA339777-D6EA-490E-87EA-C6CB8F1B05AFQ36090027-162F3B4A-1C69-4882-AAD9-32C3A086DFF8Q36229025-32FE6A4C-113A-451C-BA67-69A76DDAC0AEQ36370513-D4AD8434-AEAD-44FF-B9B6-4EC33D11730AQ36485784-CCCA9C71-CE48-4185-82F2-EF7BB7347AD4Q36832247-5E48A8B0-3791-4C4D-97E2-FDEC377743B2Q37045624-683D9E3D-5B5B-41A3-A3A5-FEDF52D85F57Q37135288-592CB4BF-1D02-43B8-94B6-FBB946C394F2Q37305861-7DCE76F0-69B7-4BA5-8EB3-7AB614AC9646Q37438848-9AC2F074-5E36-4DC1-A306-DE092DDCBE4BQ37725907-FB4903B6-8E6D-43B7-B082-58CA7E4E6F3CQ37946290-4860F46B-22A7-44C1-B9B3-18B5988A98C3Q39563381-6C545C84-8655-48D6-9A8A-7A6609B0E48AQ40246172-76E5974E-8345-41E3-8D14-299DFB45A399Q40800255-6D92BB73-F5AA-4D34-A3E1-540961AD2B63Q41763394-81072D72-7727-4138-9CE4-F1AE3998784DQ41968239-947A7E11-594C-4AFF-8BC5-49C70E4FAFCBQ42017681-A0126F7D-0A0B-40EC-A5E5-CCAA74A4C4F6Q47229243-2F548C58-9FAC-4722-B473-1ED6F17A06E1Q48229709-693FE1C8-C8B7-47F6-AD98-B8AD83E86889Q52021882-E0859C37-EF33-4A18-82EA-3342E6F28163Q54209299-871DEE6D-2A93-42EF-B97B-5E2049BFEB49Q55312563-6EEC2EC9-C24A-4DAF-B5D7-B4B7DDB80474Q55664805-0A2BD5F1-5133-4BB8-BEF5-B43D63BD86D4
P2860
Aspirin and risk for gastric cancer: a population-based case-control study in Sweden
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Aspirin and risk for gastric cancer: a population-based case-control study in Sweden
@ast
Aspirin and risk for gastric cancer: a population-based case-control study in Sweden
@en
Aspirin and risk for gastric cancer: a population-based case-control study in Sweden
@nl
type
label
Aspirin and risk for gastric cancer: a population-based case-control study in Sweden
@ast
Aspirin and risk for gastric cancer: a population-based case-control study in Sweden
@en
Aspirin and risk for gastric cancer: a population-based case-control study in Sweden
@nl
prefLabel
Aspirin and risk for gastric cancer: a population-based case-control study in Sweden
@ast
Aspirin and risk for gastric cancer: a population-based case-control study in Sweden
@en
Aspirin and risk for gastric cancer: a population-based case-control study in Sweden
@nl
P2093
P2860
P356
P1476
Aspirin and risk for gastric cancer: a population-based case-control study in Sweden
@en
P2093
A M Ekström
L B Signorello
L E Hansson
P2860
P2888
P356
10.1054/BJOC.2001.1702
P407
P577
2001-04-06T00:00:00Z
P5875
P6179
1027485077